Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
about
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionUse of intravenous immunoglobulin in acquired immune deficiency syndrome.Zidovudine for prophylaxis of human immunodeficiency virus infection after accidental exposureDifferential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1.Clinical, virological and immunological features of primary HIV-1 infectionFive cases of erroneously diagnosed HIV infection.Conflicting rights of patients and health care workers exposed to blood-borne infection.Magnetic resonance imaging of soft tissue infection with iron oxide labeled granulocytes in a rat model.Zidovudine (Retrovir) updateEvidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacyEscape from collective denial: HIV transmission during surgeryAntiretroviral therapy: reverse transcriptase inhibition.Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.Review of management of incidents involving exposure to blood in a London teaching hospital, 1989-91Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.Antiviral therapy: current concepts and practicesPre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine responseHIV infection in healthcare workers. How great is the risk? What can be done before and after exposure?State-of-the-art of zidovudine monitoring.Human immunodeficiency virus and reproduction.Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.Prophylaxis of HIV infection following occupational exposure.Reduction in incidence of glove perforation during laparotomy wound closure by 'no touch' technique.Primary HIV infection. Early diagnosis and treatment are critical to outcome.An ethics committee's recommendations on testing patients for HIV antibodies when health care workers suffer exposure to blood-borne pathogens.Occupational HIV infection: Can we talk?Zidovudine after occupational exposure to HIV.HIV infection in 1990: rapid spread in several developing countries and still insufficient preventive strategies.Zidovudine after occupational exposure to HIV.Risk of health care professionals acquiring HIV infection in Latin America.Health care workers and HIV/AIDS
P2860
Q22241902-C0A054CB-4C88-4D98-B9EB-AC32E17056FEQ33381127-184E376A-4532-498E-AFDE-B052EE9B3AFDQ33559567-4AEEA51D-4408-4423-8CC7-FFABF35726B8Q33754889-172391F9-18A5-410E-8568-7EF3B96C67F3Q33854857-3BA91128-CD1A-4A54-A385-12B4926FC851Q33933276-8045B801-9E48-439A-82C4-E699E1C1FE05Q34274611-51E3876D-187D-427D-AB0B-294FF2230EA0Q34274926-0D390ECA-05A9-433D-BAAB-CC70BA1BD9E7Q34511110-DA4C91FA-8F58-4FE1-B1E4-319D8C604AD4Q34579638-B912B5F4-A606-463A-AE56-71A6175F247CQ35127088-58040971-B58A-4E56-B82D-09F4B93FE69FQ35180573-226AE699-F87D-4A1C-A49F-D9006CA5F9AEQ35322871-3B09A65E-6772-41EC-92F5-E2EB920FB7D3Q35835028-F19233C3-8041-49DA-A9CD-B6176EA1FAA1Q35861248-3B622CF3-253D-404F-96B0-F6579E2AF6D3Q35947805-E949CD15-AA23-4F32-9621-ACF8424A9C8BQ36070394-99C3E20D-1CDE-4590-9B34-A04A32A8FD6FQ36758266-BEDEDE9F-C536-4316-92FF-BC67C647559AQ37640048-E9ED8F4F-FF3D-4637-AC52-280FA1C92DBAQ37649525-610A85B7-E95C-4513-8BAD-ABF63213A561Q37768731-EAA715C7-3317-44EE-8836-7A0DE603E9F7Q39439717-A5432330-0504-45CD-8FE0-104024B0FF1AQ40785849-1358407E-9A77-40D5-B80F-D0340736838DQ41157600-25612FBA-A7CC-44A5-97BA-608774009EC5Q41615487-3C539149-5166-47FE-8CC1-A728E723F4A7Q41623326-10C7DC7F-8088-4931-9225-4DFE2C88868CQ42576824-51762FF6-0794-4FC9-8792-D82711F4068FQ42856447-F4698C43-C2A4-4FF4-9515-9A7600B0258BQ44298756-4913E81D-298E-404B-8D99-212ADAB4B429Q45258673-C86173F6-BCD9-47F8-AAC2-93E3CDC600E4Q52265767-8EC4742C-047C-43C3-AD88-786F3EB6608CQ58106610-B4D35AD0-F86D-4193-95EF-1093B065D3E4
P2860
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@en
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@nl
type
label
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@en
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@nl
prefLabel
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@en
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@nl
P2093
P1476
Failure of zidovudine prophylaxis after accidental exposure to HIV-1.
@en
P2093
Boucher CA
Goudsmit J
Wiltink EH
van Royen EA
P304
P356
10.1056/NEJM199005103221907
P407
P577
1990-05-01T00:00:00Z